Exploring the Dynamics of Immune Checkpoint Inhibitor‐Induced Eosinophilia in Advanced/Metastatic Melanoma: A Comprehensive Retrospective Analysis
This study marks the first comprehensive approach of the relationship between the type of immunotherapy and the incidence of eosinophilia in melanoma patients. It also delves into the patients' baseline characteristics, diagnostic assessment, management, and prognosis, providing useful guidance for physicians treating patients with ICIs.
Authors
- Panagiotis Diamantopoulos (ORCID: https://orcid.org/0000-0003-2692-5944)
- Panagiotis Kouzis
- G. Kyriakakis (ORCID: https://orcid.org/0000-0003-1153-4289)
- Amalia Anastasopoulou (ORCID: https://orcid.org/0000-0002-2147-7583)
- Aikaterini Gkoufa (ORCID: https://orcid.org/0000-0001-5644-8208)
- Helen J Gogas (ORCID: https://orcid.org/0000-0002-0451-2885)
- G. Lyrarakis
Institutions
- National and Kapodistrian University of Athens (GR)
- Laiko General Hospital of Athens (GR)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1002/cam4.70679
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09